van Houte Hans insider trades
van Houte Hans has filed 39 Form 4s with the SEC that we hold, all for Nurix Therapeutics, Inc. (NRIX), as Chief Financial Officer. Across all of them we count 0 purchases worth $0 and 38 sales worth $2.5M reported on Form 4. In the last 12 months: 0 purchases ($0) and 10 sales ($635.4K). The largest single trade was a sale of 20,000 shares of Nurix Therapeutics, Inc. worth $504.4K, dated 2024-08-26. The first filing on our record is dated 2022-01-21 and the latest 2026-08-04.
Nurix Therapeutics, Inc. (NRIX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-02 | S, sale reported on Form 4 | 697 | $8.2K | 2022-05-03 |
| 2022-08-01 | S, sale reported on Form 4 | 752 | $11.8K | 2022-08-02 |
| 2022-10-31 | S, sale reported on Form 4 | 739 | $9.5K | 2022-11-01 |
| 2023-01-30 | S, sale reported on Form 4 | 924 | $10.9K | 2023-02-01 |
| 2023-05-01 | S, sale reported on Form 4 | 721 | $7.1K | 2023-05-02 |
| 2023-07-31 | S, sale reported on Form 4 | 1,245 | $12.0K | 2023-08-01 |
| 2023-10-31 | S, sale reported on Form 4 | 1,080 | $5.6K | 2023-11-01 |
| 2023-12-19 | S, sale reported on Form 4 | 10,906 | $109.1K | 2023-12-20 |
| 2023-12-20 | S, sale reported on Form 4 | 3,541 | $35.4K | 2023-12-21 |
| 2024-01-30 | S, sale reported on Form 4 | 1,671 | $13.4K | 2024-01-30 |
| 2024-02-16 | S, sale reported on Form 4 | 6,812 | $68.3K | 2024-02-16 |
| 2024-04-30 | S, sale reported on Form 4 | 1,387 | $16.7K | 2024-04-30 |
| 2024-05-02 | S, sale reported on Form 4 | 3,499 | $44.9K | 2024-05-02 |
| 2024-06-20 | S, sale reported on Form 4 | 20,000 | $400.2K | 2024-06-20 |
| 2024-07-30 | S, sale reported on Form 4 | 2,490 | $51.5K | 2024-07-30 |
| 2024-08-01 | S, sale reported on Form 4 | 3,377 | $72.4K | 2024-08-01 |
| 2024-08-01 | S, sale reported on Form 4 | 100 | $2.2K | 2024-08-01 |
| 2024-08-26 | S, sale reported on Form 4 | 20,000 | $504.4K | 2024-08-26 |
| 2024-10-30 | S, sale reported on Form 4 | 2,368 | $57.6K | 2024-10-30 |
| 2024-11-01 | S, sale reported on Form 4 | 3,546 | $86.1K | 2024-11-01 |
| 2025-01-30 | S, sale reported on Form 4 | 254 | $5.2K | 2025-01-30 |
| 2025-01-30 | S, sale reported on Form 4 | 2,557 | $50.7K | 2025-01-30 |
| 2025-03-03 | S, sale reported on Form 4 | 700 | $10.6K | 2025-03-03 |
| 2025-03-03 | S, sale reported on Form 4 | 5,125 | $73.8K | 2025-03-03 |
| 2025-04-30 | S, sale reported on Form 4 | 2,438 | $28.0K | 2025-04-30 |
| 2025-05-02 | S, sale reported on Form 4 | 6,198 | $70.2K | 2025-05-02 |
| 2025-07-30 | S, sale reported on Form 4 | 4,304 | $51.7K | 2025-07-30 |
| 2025-08-01 | S, sale reported on Form 4 | 5,402 | $59.6K | 2025-08-01 |
| 2025-10-30 | S, sale reported on Form 4 | 3,130 | $40.1K | 2025-10-30 |
| 2025-11-03 | S, sale reported on Form 4 | 6,284 | $78.9K | 2025-11-03 |
| 2026-01-30 | S, sale reported on Form 4 | 73 | $1.3K | 2026-01-30 |
| 2026-01-30 | S, sale reported on Form 4 | 3,588 | $59.5K | 2026-01-30 |
| 2026-04-30 | S, sale reported on Form 4 | 2,388 | $39.8K | 2026-04-30 |
| 2026-05-05 | S, sale reported on Form 4 | 582 | $10.0K | 2026-05-05 |
| 2026-05-05 | S, sale reported on Form 4 | 13,473 | $223.4K | 2026-05-05 |
| 2026-07-30 | S, sale reported on Form 4 | 2,845 | $66.5K | 2026-07-30 |
| 2026-08-04 | S, sale reported on Form 4 | 1,794 | $42.9K | 2026-08-04 |
| 2026-08-04 | S, sale reported on Form 4 | 2,967 | $73.1K | 2026-08-04 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1817217) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms